XT
ORIC icon

XTX Topco’s Oric Pharmaceuticals ORIC Stock Holding History

XTX Topco’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$548K Sell
43,291
-67,274
-61% -$764K 0.01% 1968
2025
Q4 		$904K Buy
+110,565
New +$1.27M 0.02% 1096
2025
Q2 		– Sell
-19,077
Closed -$106K – 2952
2025
Q1 		$106K Sell
19,077
-6,889
-27% -$60.2K 0.01% 1858
2024
Q4 		$210K Buy
25,966
+14,209
+121% +$130K 0.02% 1519
2024
Q3 		$121K Sell
11,757
-9,881
-46% -$97.7K 0.01% 1573
2024
Q2 		$153K Buy
+21,638
New +$194K 0.01% 1322
2023
Q4 		– Sell
-11,320
Closed -$68.5K – 1973
2023
Q3 		$68.5K Buy
+11,320
New +$92.8K 0.01% 1233
2022
Q4 		– Sell
-38,411
Closed -$123K – 1400
2022
Q3 		$123K Buy
38,411
+18,052
+89% +$72.3K 0.03% 906
2022
Q2 		$91K Buy
+20,359
New +$81.2K 0.04% 665

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

XTX Topco's ORIC Position: Q1 2026 in Review

XTX Topco reduced its Oric Pharmaceuticals (ORIC) stake by 61% in Q1 2026, selling an estimated $764K and leaving 43,291 shares worth $548K. The position accounts for 0.01% of the portfolio, ranked #1968.

XTX Topco first reported a position in ORIC in Q2 2022 and has held it in 9 quarters since. The position peaked at $904K in Q4 2025. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • XTX Topco held 43,291 shares of Oric Pharmaceuticals worth $548K as of Q1 2026.
  • XTX Topco sold 67,274 Oric Pharmaceuticals shares in Q1 2026, an estimated $764K.
  • Oric Pharmaceuticals made up 0.01% of XTX Topco's portfolio in Q1 2026, its #1968 holding.
  • XTX Topco first reported a position in Oric Pharmaceuticals in Q2 2022 and has held it in 9 quarters since.
  • XTX Topco's Oric Pharmaceuticals position peaked at $904K in Q4 2025.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.